Challenges of Integrating Biosimilars Into Clinical Practice
Presented by Kate Jeffers,(1) PharmD, MHA, BCOP, Megan May,(2) PharmD, BCOP, and Wendy H. Vogel,(3) MSN, FNP, AOCNP®
From (1)UCHealth Memorial Hospital, Colorado Springs, Colorado; (2)Baptist Health, Lexington, Kentucky; (3)Wellmont Cancer Institute, Kingsport, Tennessee
Presenters’ disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2020;11(3):245–248 |
© 2020 Harborside™
Presenters at JADPRO Live 2019 discussed the chemical and clinical nature of biosimilars, reviewed biosimilar development in oncology, and discussed implementation strategies for biosimilars.
For access to the full length article, please sign in